PA
NVAX icon

Perceptive Advisors’s Novavax NVAX Stock Holding History

Perceptive Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,043,000
Closed -$116M – 154
2020
Q4 		$116M Buy
1,043,000
+335,285
+47% +$35.6M 1.25% 20
2020
Q3 		$76.7M Buy
707,715
+357,715
+102% +$43.6M 1.12% 24
2020
Q2 		$29.2M Buy
+350,000
New +$13.4M 0.47% 50
2017
Q1 		– Sell
-16,771
Closed -$423K – 190
2016
Q4 		$423K Buy
+16,771
New +$489K 0.03% 129
2016
Q3 		– Sell
-1,600
Closed -$233K – 212
2016
Q2 		$233K Buy
+1,600
New +$183K 0.02% 142

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors's NVAX Position: Q1 2021 in Review

Perceptive Advisors sold out of Novavax (NVAX) in Q1 2021, closing a stake of 1,043,000 shares — an estimated $116M sold.

Perceptive Advisors first reported a position in NVAX in Q2 2016 and held it in 5 quarters. The position peaked at $116M in Q4 2020. 389 funds tracked by Wall St. Rank hold NVAX as of Q1 2021.

  • Perceptive Advisors reported no remaining Novavax position as of Q1 2021 after selling out during the quarter.
  • Perceptive Advisors sold 1,043,000 Novavax shares in Q1 2021, an estimated $116M.
  • Perceptive Advisors first reported a position in Novavax in Q2 2016 and held it in 5 quarters.
  • Perceptive Advisors's Novavax position peaked at $116M in Q4 2020.
  • 389 funds tracked by Wall St. Rank held Novavax as of Q1 2021.

Based on Perceptive Advisors's 13F filing for Q1 2021, filed 17 May 2021.